Jean-Paul Roduit

This inventor holds 38 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Amino Alcohol Derivatives. Top assignees: Lonza Ag, Lonza Inc., Idorsia Pharmaceuticals Ltd. Active years: 1993-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Paul Roduit. Retrieved from https://idiyas.com/inventor/jean-paul-roduit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 38 (Patent Applications = 2)

% Patents Active = 84.2

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 45(Granted Patents)

Location History:

Gr{circumflex over (o)}ne, CH (2001)
Grône, CH (2001 - 2004)
Gröne, CH (2007)
Grone, CH (1996 - 2008)
Sierre, CH (1993 - 2023)

Company Filing History:

Idorsia Pharmaceuticals Ltd

6. 1 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2023

Loading Chart...

Areas of Expertise:

Amino Alcohol Derivatives

Pyridine Esters

Aryl Amides

Heteroaromatic Carboxylic Acids

Biotechnological Processes

Piperazine Derivatives

Microbiological Processes

Crystalline Forms

Tetrahydropyrazine

Imidazopyridine

Carboxylic Acid Chlorides

7-Acylindoles

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11713297 - Crystalline form of N-butyldeoxygalactonojirimycin (2023-08-01),

2. 11306058 - Crystalline form of N-butyldeoxygalactonojirimycin (2022-04-19),

3. 7358073 - Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4(2-amino-6-chloro-5-formamido-4- pyrimidinyl)-amino-2-cyclopentenyl-1-methanol (2008-04-15),

4. 7355048 - Process for preparing 1-(6-methylpyridin-3-yl)-2-[4- (methylsulphonyl)phenyl]ethanone (2008-04-08),

5. 7338945 - Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4(2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino-2-cyclopentenyl-1-methanol (2008-03-04),

6. 7229981 - Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-(2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol (2007-06-12),

7. 7141673 - 1-(6-methylpyridine-3-yl)-2-[4-(methylsulphonyl) phenyl] ethanone and method for its preparation (2006-11-28),

8. 7009058 - Method for preparing pyridine-2,3-dicarboxylic acid esters (2006-03-07),

9. 6723868 - Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol (2004-04-20),

10. 6635766 - Process for the preparation of arylamides of heteroaromatic carboxylic acids (2003-10-21),

11. 6448402 - Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol (2002-09-10),

12. 6271372 - Process for the preparation of arylamides of heteroaromatic carboxylic acids (2001-08-07),

13. 6214604 - Biotechnical production process of piperazine R-&agr;-carboxylic acids and piperazine S-&agr;-carboxylic acid amide (2001-04-10),

14. 6175011 - Process for the preparation of arylamides of heteroaromatic carboxylic acids (2001-01-16),

15. 6169183 - Process for preparing pyridinecarboxylic esters (2001-01-02),

Title: The Visionary Inventor: Jean-Paul Roduit's Pursuit of Excellence

Introduction: Jean-Paul Roduit, a visionary inventor hailing from Grone, CH, has left an indelible mark on the world of innovation with his relentless pursuit of excellence. With an impressive portfolio of 38 patents, Roduit's passion for pushing boundaries and creating groundbreaking solutions has positioned him as a trailblazer in the field of inventing.

Latest Patents: Among his latest patents is the invention of a crystalline form of N-butyldeoxygalactonojirimycin. This groundbreaking discovery offers new possibilities in pharmaceutical compositions as a glycolipid biosynthesis inhibitor, showcasing Roduit's ability to innovate in crucial areas of medicine and healthcare.

Career Highlights: Throughout his illustrious career, Roduit has navigated the complexities of innovation with finesse. His tenure at Lonza AG and Lonza Inc. has been marked by a string of achievements, solidifying his reputation as a pioneering force within the industry. Roduit's dedication to excellence is evident in each of his patented inventions, reflecting his commitment to driving progress and shaping the future.

Collaborations: Collaboration has been a cornerstone of Roduit's success, with notable partnerships including Alain Wellig and Yves Bessard. Together, they have pushed the boundaries of what is possible, leveraging their collective expertise to create innovative solutions that have the potential to change lives.

Conclusion: In conclusion, Jean-Paul Roduit's visionary spirit and dedication to innovation have positioned him as a leading figure in the world of invention. His impact will undoubtedly be felt for generations to come, inspiring future inventors to push the boundaries of what is possible. As we look to the future of innovation, we can draw inspiration from Roduit's unwavering commitment to excellence and his relentless pursuit of groundbreaking solutions.

Profile summary based on public USPTO records.